Fmoc-(RS)-3-amino-3-(4-trifluoromethylphenyl)-propionic acid, 97%, 10g

Tenalisib, 100mg

TERT-BUTYL 4-METHOXYPIPERIDINE-1-CARBOXYLATE, 95.0%, 5g

2-BROMO-6-FLUORO-4-PYRIDINECARBOXYLIC ACID, 97.0%, 1g

1-(tert-Butoxy)-2-methylpropane, 95.0%, 50mg

5-(2-Methoxyphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 5g

2-Bromoanthraquinone, 97.0%, 5g

(2-Butoxy-5-(trifluoromethyl)pyridin-3-yl)boronic acid, 95.0%, 1g

(R)-(-)-(3,5-Dioxa-4-phosphacyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)dimethylamine>98.0%(HPLC)(N)5g

Ethyl-2-cyanopropionate, 97.0%, 25g

H-D-Lys(N3).HCl, 98.0%, 250mg

(E)-{Phenyl[(E)-(phenylmethylidene)amino]methyl}-(phenylmethylidene)amine, 96.0%, 250mg

4-bromo-1-(2,2-diethoxyethyl)-1H-pyrazole, 1g